Terms: = Breast cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
7939 results:
1. [Feasibility analysis of the application of programmed process endoscopic lateral neck dissection via chest-breast approach in papillary thyroid carcinoma surgery].
Xu N; Li ZY; Luo XP; Gao HY; Huang JF; Wang YY; Liu XJ; Xu B
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1831-1836. PubMed ID: 38782751
[No Abstract] [Full Text] [Related]
2. Noninvasive Assessment of Tumor Histological Grade in Invasive breast Carcinoma Based on Ultrasound Radiomics and Clinical Characteristics: A Multicenter Study.
Ge L; Wu J; Jin Y; Xu D; Wang Z
Technol Cancer Res Treat; 2024; 23():15330338241257424. PubMed ID: 38780506
[No Abstract] [Full Text] [Related]
3. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
[TBL] [Abstract] [Full Text] [Related]
4. Dermaseptin B2 bioactive gene's potential for anticancer and anti-proliferative effect is linked to the regulation of the BAX/BBC3/akt pathway.
Nasirabadi FK; Doosti A
Med Oncol; 2024 May; 41(6):162. PubMed ID: 38767753
[TBL] [Abstract] [Full Text] [Related]
5. CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/akt/mTOR activation.
Li Y; Wang Z; Yang J; Sun Y; He Y; Wang Y; Chen X; Liang Y; Zhang N; Wang X; Zhao W; Hu G; Yang Q
Mol Cancer; 2024 May; 23(1):102. PubMed ID: 38755678
[TBL] [Abstract] [Full Text] [Related]
6. Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in breast cancer.
Yang Z; Wang Y; Huang S; Geng Y; Yang Z; Yang Z
PLoS One; 2024; 19(5):e0303650. PubMed ID: 38753638
[TBL] [Abstract] [Full Text] [Related]
7. Mechanistic exploration and experimental validation of the Xiaochaihu decoction for the treatment of breast cancer by network pharmacology.
Liu Q; Luo Z; Sun M; Li W; Liu S
Aging (Albany NY); 2024 May; 16(9):7979-7999. PubMed ID: 38742934
[TBL] [Abstract] [Full Text] [Related]
8. Type II Interleukin-4 Receptor Activation in Basal breast cancer Cells Promotes Tumor Progression via Metabolic and Epigenetic Modulation.
Williams D; Hargrove-Wiley E; Bindeman W; Valent D; Miranda AX; Beckstead J; Fingleton B
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731867
[TBL] [Abstract] [Full Text] [Related]
9. Nuclear Softness Promotes the Metastatic Potential of Large-Nucleated Colorectal cancer Cells via the ErbB4-akt1-Lamin A/C Signaling Pathway.
Li Y; Li Q; Mu L; Hu Y; Yan C; Zhao H; Mi Y; Li X; Tao D; Qin J
Int J Biol Sci; 2024; 20(7):2748-2762. PubMed ID: 38725859
[TBL] [Abstract] [Full Text] [Related]
10. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment.
Cui Y; Ran R; Da Y; Zhang H; Jiang M; Qi X; Zhang W; Niu L; Zhou Y; Zhou C; Tang X; Wang K; Yan Y; Ren Y; Dong D; Zhou Y; Wang H; Gong J; Hu F; Zhao S; Zhang H; Zhang C; Yang J
J Cell Mol Med; 2024 May; 28(9):e18374. PubMed ID: 38722288
[TBL] [Abstract] [Full Text] [Related]
11. The Human Intermediate Prolactin Receptor I-tail Contributes breast Oncogenesis by Targeting Ras/MAPK Pathway.
Shen S; Radhakrishnan SK; Harrell JC; Puchalapalli M; Koblinski J; Clevenger C
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38713636
[TBL] [Abstract] [Full Text] [Related]
12. [Study of antitumor effects of human placenta hydrolysate on PC-3, OAW-42, BT-474 cell cultures].
Gromova OA; Filimonova MV; Torshin IY; Frolova DЕ
Ter Arkh; 2024 Apr; 96(3):266-272. PubMed ID: 38713042
[TBL] [Abstract] [Full Text] [Related]
13. Glucagon-like peptide-1 analogs activate AMP kinase leading to reversal of the Warburg metabolic switch in breast cancer cells.
Ligumsky H; Amir S; Arbel Rubinstein T; Guion K; Scherf T; Karasik A; Wolf I; Rubinek T
Med Oncol; 2024 May; 41(6):138. PubMed ID: 38705935
[TBL] [Abstract] [Full Text] [Related]
14. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract] [Full Text] [Related]
15. Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing cancer Metastasis.
Tsai HE; Chen CL; Chang TT; Fu CW; Chen WC; Perez SJLP; Hsiao PW; Tai MH; Li WS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673867
[TBL] [Abstract] [Full Text] [Related]
16. Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.
Han JY; Che N; Mo J; Zhang DF; Liang XH; Dong XY; Zhao XL; Sun BC
BMC Cancer; 2024 Apr; 24(1):532. PubMed ID: 38671389
[TBL] [Abstract] [Full Text] [Related]
17. CircPDE5A-encoded novel regulator of the PI3K/akt pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
[TBL] [Abstract] [Full Text] [Related]
18. Elongin B promotes breast cancer progression by ubiquitinating tumor suppressor p14/ARF.
Sui XY; Ma XY; Hou Y; Cao SW; Wang ZQ; Jia LJ; Fan L; Shao ZM; Zhang WJ
Cell Biol Toxicol; 2024 Apr; 40(1):24. PubMed ID: 38653919
[TBL] [Abstract] [Full Text] [Related]
19. Tumor-associated macrophage subtypes on cancer immunity along with prognostic analysis and SPP1-mediated interactions between tumor cells and macrophages.
Xu L; Chen Y; Liu L; Hu X; He C; Zhou Y; Ding X; Luo M; Yan J; Liu Q; Li H; Lai D; Zou Z
PLoS Genet; 2024 Apr; 20(4):e1011235. PubMed ID: 38648200
[TBL] [Abstract] [Full Text] [Related]
20. Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1-3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study.
Bae SJ; Chun JW; Lee SB; Ryu JM; Nam SJ; Jeong J; Park HS; Ahn SG
Breast Cancer Res; 2024 Apr; 26(1):66. PubMed ID: 38632652
[TBL] [Abstract] [Full Text] [Related]
[Next]